Oliviero James F III 4
4 · Checkpoint Therapeutics, Inc. · Filed May 24, 2024
Insider Transaction Report
Form 4
Oliviero James F III
DirectorCEO, President and Director
Transactions
- Award
COMMON STOCK (RESTRICTED)
2024-05-24+1,660,000→ 2,001,780 total
Footnotes (2)
- [F1]The shares of restricted stock vest as follows: one-third on January 31, 2025, one-third on January 31, 2026 and one-third on January 31, 2027.
- [F2]Includes shares of restricted common stock, which vest over various time periods.